A new program from the health company Express Scripts could soon make insulin available to patients at $25 for a monthlong supply, at most.
A new program from the health company Express Scripts, which is owned by health insurer Cigna, aims to change that by maxing out how much individuals with diabetes pay for a monthlong supply at just $25. Six million Americans rely on insulin each day, according to the American Diabetes Association, and the escalating cost of insulin has become a major problem for them. Frequent'Serendipitous' timingThe issue has also caught the attention of Congress. The Senate Finance Committee has called Cigna/Express Scripts and companies like it to appear at an April 9 hearing about drug prices, where they're likely to face some tough questions.